LDHA and neoplasm: Sodium oxalate (OXA) or FX11 can inhibit LDHA, directly reducing lactate production, thereby (1) blocking PCK‐K100la induced ferroptosis to alleviate ischemia–reperfusion injury [23], (2) inhibiting MRE11‐K673la and NBS1‐K388la induced DNA homologous repair recombination [20, 32], (3) reducing myopia induced by H3K18la [46], (4) inhibiting autophagy‐dependent survival of tumour cells [74].